8-K: Safety Shot Restructures Debt, Issues New Preferred Stock and Reprices Warrants Amidst Financial Maneuvers

Safety Shot, Inc. has announced a significant financial restructuring, exchanging over $5.4 million in convertible notes for new Series B Preferred Stock and reducing the exercise price of existing warrants, aiming to bolster its balance sheet and manage debt maturities.

Summary

• Safety Shot, Inc. executed an Amendment No. 1 to its Securities Purchase Agreement on July 2, 2025, reducing the exercise price of warrants from $0.4348 per share to $0.33 per share for 5,332,889 shares of Common Stock.
• The company entered into an Exchange Agreement on July 2, 2025, with two accredited investors (Trajan Holdings LLC and Fried LLC) to convert existing debt into equity.
• Investors exchanged a Secured Convertible Note with a principal of $1,750,000 (outstanding principal and accrued interest of $1,768,525 as of July 1, 2025) and a Convertible Note with a principal of $3,500,000 (outstanding principal and accrued interest of $3,640,000 as of July 1, 2025).
• The total outstanding principal and accrued interest of the exchanged notes amounted to $5,408,525.
• In exchange for the notes, the investors received an aggregate of 7,212 shares of newly designated Series B Convertible Preferred Stock.
• The Series B Preferred Stock has a stated value of $750 per share and is convertible into Common Stock at a conversion price of $0.34 per share.
• The conversion is subject to a beneficial ownership limitation, initially 4.99% of outstanding Common Stock, which can be increased to 9.99% with 61 days' notice.
• The company will pay $25,000 in legal fees and expenses for the Holders' advisers related to the Exchange Agreement.
• The exchange transaction is intended to be exempt from registration under Section 3(a)(9) of the Securities Act, allowing the holding period of the new Series B Preferred Stock to tack back to the original Convertible Notes for Rule 144 purposes.
• The company is subject to liquidated damages if it fails to deliver conversion shares on time ($50 per Trading Day, increasing to $100, then $200 for each $5,000 of Stated Value) or fails to maintain public information requirements under Rule 144(c) (2.0% of aggregate Subscription Amount per failure day/period).

Sentiment

Score: 3

Explanation: The sentiment is negative due to the significant potential dilution from the repriced warrants and the low conversion price of the new preferred stock. While debt conversion improves the balance sheet, the terms heavily favor investors, suggesting the company is in a distressed financial position or has limited alternatives. The punitive clauses for non-compliance further underscore this.

Positives

• The exchange of convertible notes for Series B Preferred Stock reduces the company's immediate debt obligations and extends the maturity profile, improving balance sheet liquidity.
• The conversion of debt to equity can strengthen the company's equity base and potentially reduce interest expense, which is beneficial for financial health.
• The transaction is structured to qualify for a Section 3(a)(9) exemption, simplifying the regulatory process for the exchange.

Negatives

• The reduction of the warrant exercise price from $0.4348 to $0.33 per share significantly increases potential dilution for existing common shareholders at a lower price point.
• The conversion price of $0.34 per share for the Series B Preferred Stock is very low, indicating substantial potential dilution upon conversion.
• The company is obligated to pay the investors' legal fees of $25,000, which is an additional cost.
• The inclusion of punitive liquidated damages for failure to deliver conversion shares or maintain public information suggests a weaker negotiating position for the company and potential past compliance issues or high investor demands.

Risks

• Significant potential dilution for existing common shareholders due to the reduced warrant exercise price and the low conversion price of the Series B Preferred Stock.
• Financial penalties (liquidated damages) if the company fails to timely deliver conversion shares or maintain compliance with public information requirements under Rule 144.
• The company's obligation to reserve a substantial number of Common Stock shares for future conversions could limit its flexibility for other equity-based financing or corporate actions.
• The 'Most Favored Nations' clause could restrict the company's ability to offer more favorable terms to future investors without extending those terms to the current holders.

Future Outlook

The company's future outlook is focused on managing its capital structure by converting existing debt into equity and adjusting warrant terms. This aims to reduce immediate cash outflows and extend debt maturities, potentially providing more financial flexibility. The company also commits to maintaining its Nasdaq listing and timely SEC filings.

Management Comments

• Jarrett Boon, Chief Executive Officer, signed the report on behalf of Safety Shot, Inc.

Industry Context

This type of debt-to-equity conversion and warrant repricing is often seen in companies seeking to improve their balance sheet health, reduce leverage, and manage upcoming debt maturities, particularly in growth-stage or financially constrained companies. It can be a strategic move to avoid default or to clean up the capital structure to attract new investment, though the terms offered to investors (low conversion price, reduced warrant exercise price, and punitive clauses) suggest the company may be in a less favorable negotiating position compared to industry peers with stronger financial standing.

Comparison to Industry Standards

• The reduction of warrant exercise price and the low conversion price for preferred stock are generally below industry standards for healthy, growing companies, indicating a significant concession to investors, possibly due to financial distress or a strong need for capital restructuring.
• The inclusion of liquidated damages for failure to deliver shares or maintain public information is a strong protective measure for investors, often seen in agreements with companies perceived as higher risk or those with a history of non-compliance, which is not a standard term for robust companies.
• Paying the investors' legal fees is also less common in standard financing rounds for financially strong companies, further suggesting the company's need to incentivize the transaction.

Corporate Governance

Stakeholder Impact

• Shareholders: Face significant potential dilution due to the reduced warrant exercise price and the low conversion price of the Series B Preferred Stock. Their voting power could also be diluted upon conversion of the preferred stock.
• Creditors (Holders of Convertible Notes): Benefit from the conversion of their debt into equity, potentially improving their recovery prospects and aligning their interests with the company's equity performance. They also receive protective clauses and legal fee coverage.
• Company Management: Gains flexibility by reducing immediate debt obligations and extending maturities, but must adhere to strict compliance terms to avoid penalties.

Next Steps

• The company is required to file a Current Report on Form 8-K, including the Transaction Documents as exhibits, by July 9, 2025.
• The company must maintain its Nasdaq listing and timely file all required reports with the SEC.
• The company must reserve and keep available sufficient authorized and unissued shares of Common Stock for the conversion of the Series B Preferred Stock.

Key Dates

Recommendation

Keywords

Debt Restructuring, Convertible Notes, Preferred Stock, Warrants, Equity Financing, Dilution, SEC Filing, Form 8-K, Corporate Governance, Financial Health, Capital Structure